Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 213 articles:
HTML format



Single Articles


    January 2024
  1. KIM M, Kim D, Kang H, Park S, et al
    A machine learning model for prediction of sarcopenia in patients with Parkinson's Disease.
    PLoS One. 2024;19:e0296282.
    PubMed     Abstract available


  2. BRUNI F, Mancuso V, Stramba-Badiale C, Stramba-Badiale M, et al
    Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.
    PLoS One. 2024;19:e0294199.
    PubMed     Abstract available


  3. SOKOLOWSKI A, Bhagwat N, Chatelain Y, Dugre M, et al
    Longitudinal brain structure changes in Parkinson's disease: A replication study.
    PLoS One. 2024;19:e0295069.
    PubMed     Abstract available


  4. ESSAWY ESSAWY A, Abou-ElNaga OA, Mehanna RA, Badae NM, et al
    Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
    PLoS One. 2024;19:e0296297.
    PubMed     Abstract available


  5. WAWRZICZNY E, Flinois B, Constant E, Brugalle E, et al
    Dealing with the diagnosis of Parkinson's disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis.
    PLoS One. 2024;19:e0294240.
    PubMed     Abstract available


  6. MEIJER LL, Ruis C, Schielen ZA, Dijkerman HC, et al
    CT-optimal touch and chronic pain experience in Parkinson's Disease; An intervention study.
    PLoS One. 2024;19:e0298345.
    PubMed     Abstract available


    January 2023

  7. Expression of Concern: Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
    PLoS One. 2023;18:e0280116.
    PubMed    


  8. ABRAHAM A, Bay AA, Ni L, Schindler N, et al
    Gender differences in motor and non-motor symptoms in individuals with mild-moderate Parkinson's disease.
    PLoS One. 2023;18:e0272952.
    PubMed     Abstract available


  9. MA A, Desai N, Lau KK, Palaniswami M, et al
    Automated measurement of inter-arytenoid distance on 4D laryngeal CT: A validation study.
    PLoS One. 2023;18:e0279927.
    PubMed     Abstract available


  10. LONGARDNER K, Wright BA, Alakkas A, You H, et al
    Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis.
    PLoS One. 2023;18:e0278262.
    PubMed     Abstract available


  11. HAPUTHANTHIRIGE NKH, Sullivan K, Moyle G, Brauer S, et al
    Effects of dance on gait and dual-task gait in Parkinson's disease.
    PLoS One. 2023;18:e0280635.
    PubMed     Abstract available


  12. DUARTE JDS, Alcantara WA, Brito JS, Barbosa LCS, et al
    Physical activity based on dance movements as complementary therapy for Parkinson's disease: Effects on movement, executive functions, depressive symptoms, and quality of life.
    PLoS One. 2023;18:e0281204.
    PubMed     Abstract available


  13. CABALLOL N, Bayes A, Prats A, Martin-Baranera M, et al
    Feasibility of a wearable inertial sensor to assess motor complications and treatment in Parkinson's disease.
    PLoS One. 2023;18:e0279910.
    PubMed     Abstract available


  14. GOMEZ LF, Morales A, Fierrez J, Orozco-Arroyave JR, et al
    Exploring facial expressions and action unit domains for Parkinson detection.
    PLoS One. 2023;18:e0281248.
    PubMed     Abstract available


  15. AVENI K, Ahmed J, Borovsky A, McRae K, et al
    Predictive language comprehension in Parkinson's disease.
    PLoS One. 2023;18:e0262504.
    PubMed     Abstract available


  16. MORAITOU M, Sotiroudis G, Papagiannakis N, Ferraz MMJ, et al
    a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy.
    PLoS One. 2023;18:e0277602.
    PubMed     Abstract available


  17. BUCHWITZ TM, Ruppert-Junck MC, Greuel A, Maier F, et al
    Exploring impaired self-awareness of motor symptoms in Parkinson's disease: Resting-state fMRI correlates and the connection to mindfulness.
    PLoS One. 2023;18:e0279722.
    PubMed     Abstract available


  18. CARRICARTE NARANJO C, Sanchez Luaces C, Pedroso Ibanez I, Machado A, et al
    Beyond shallow feelings of complex affect: Non-motor correlates of subjective emotional experience in Parkinson's disease.
    PLoS One. 2023;18:e0281959.
    PubMed     Abstract available


  19. DISMORE L, Montague K, Carvalho L, Guerreiro T, et al
    A protocol for the evaluation of a wearable device for monitoring of symptoms, and cueing for the management of drooling, in people with Parkinson's disease.
    PLoS One. 2023;18:e0280727.
    PubMed     Abstract available


  20. SOOD M, Suenkel U, von Thaler AK, Zacharias HU, et al
    Bayesian network modeling of risk and prodromal markers of Parkinson's disease.
    PLoS One. 2023;18:e0280609.
    PubMed     Abstract available


  21. OHMICHI T, Kasai T, Shinomoto M, Kitani-Morii F, et al
    Serum leucine-rich alpha2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
    PLoS One. 2023;18:e0282153.
    PubMed     Abstract available


  22. SEO K, Matunari I, Yamamoto T
    Cerebral cortical thinning in Parkinson's disease depends on the age of onset.
    PLoS One. 2023;18:e0281987.
    PubMed     Abstract available


  23. CHUNG JW, Knight CA, Bower AE, Martello JP, et al
    Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson's disease.
    PLoS One. 2023;18:e0282203.
    PubMed     Abstract available


  24. CARVAJAL-OLIVEROS A, Dominguez-Baleon C, Sanchez-Diaz I, Zambrano-Tipan D, et al
    Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment.
    PLoS One. 2023;18:e0282348.
    PubMed     Abstract available


  25. ALI DE, Bassam SM, Elatrebi S, Habiba ES, et al
    HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson's disease in rats.
    PLoS One. 2023;18:e0282246.
    PubMed     Abstract available


  26. TAN QY, Roberts HC, Fraser SDS, Amar K, et al
    What are the modifiable factors of treatment burden and capacity among people with Parkinson's disease and their caregivers: A qualitative study.
    PLoS One. 2023;18:e0283713.
    PubMed     Abstract available


  27. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.
    PLoS One. 2023;18:e0283122.
    PubMed     Abstract available


  28. HWANG KS, Langley J, Tripathi R, Hu XP, et al
    In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    PLoS One. 2023;18:e0282684.
    PubMed     Abstract available


  29. CAMPI M, Peters GW, Toczydlowska D
    Ataxic speech disorders and Parkinson's disease diagnostics via stochastic embedding of empirical mode decomposition.
    PLoS One. 2023;18:e0284667.
    PubMed     Abstract available


  30. ANWER DM, Gubinelli F, Kurt YA, Sarauskyte L, et al
    A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates.
    PLoS One. 2023;18:e0284480.
    PubMed     Abstract available


  31. ALLWRIGHT M, Mundell H, Sutherland G, Austin P, et al
    Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson's disease risk.
    PLoS One. 2023;18:e0285416.
    PubMed     Abstract available


  32. MACLAGAN LC, Marras C, Sewell IJ, Wu CF, et al
    Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study.
    PLoS One. 2023;18:e0285585.
    PubMed     Abstract available


  33. HIRANO M, Samukawa M, Isono C, Nagai Y, et al
    The effects of safinamide on dysphagia in Parkinson's disease.
    PLoS One. 2023;18:e0286066.
    PubMed     Abstract available


  34. DAS J, Barry G, Walker R, Vitorio R, et al
    The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?
    PLoS One. 2023;18:e0285100.
    PubMed     Abstract available


  35. ESCHWEILER M, McCrum C, Giannouli E
    A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
    PLoS One. 2023;18:e0286402.
    PubMed     Abstract available


  36. CHAND DA, Scadeng M, Dieriks BV
    Absolute quantification of neuromelanin in formalin-fixed human brains using absorbance spectrophotometry.
    PLoS One. 2023;18:e0288327.
    PubMed     Abstract available


  37. MARTINDALE JM, Sarva H, Martino D, Gilbert DL, et al
    Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders.
    PLoS One. 2023;18:e0288408.
    PubMed     Abstract available


  38. PARAJULI M, Amara AW, Shaban M
    Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease.
    PLoS One. 2023;18:e0286506.
    PubMed     Abstract available


  39. SORRELL L, Leta V, Barnett A, Stevens K, et al
    Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
    PLoS One. 2023;18:e0285349.
    PubMed     Abstract available


  40. ZAMORA-URSULO MA, Perez-Becerra J, Tellez LA, Saderi N, et al
    Reversal of pathological motor behavior in a model of Parkinson's disease by striatal dopamine uncaging.
    PLoS One. 2023;18:e0290317.
    PubMed     Abstract available


  41. BRITO SAF, Scianni AA, Silveira BMF, Oliveira ERM, et al
    Effects of high-intensity respiratory muscle training on respiratory muscle strength in individuals with Parkinson's disease: Protocol of a randomized clinical trial.
    PLoS One. 2023;18:e0291051.
    PubMed     Abstract available


  42. CROOKS S, Carter G, Wilson CB, Wynne L, et al
    Exploring public perceptions and awareness of Parkinson's disease: A scoping review.
    PLoS One. 2023;18:e0291357.
    PubMed     Abstract available


  43. CHIU YS, Wu KJ, Yu SJ, Wu KL, et al
    Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
    PLoS One. 2023;18:e0291927.
    PubMed     Abstract available


  44. BATTISTA L, Casali M, Brusa L, Radicati FG, et al
    Clinical assessment of a new wearable tool for continuous and objective recording of motor fluctuations and ON/OFF states in patients with Parkinson's disease.
    PLoS One. 2023;18:e0287139.
    PubMed     Abstract available


  45. VOLLSTEDT EJ, Madoev H, Aasly A, Ahmad-Annuar A, et al
    Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
    PLoS One. 2023;18:e0292180.
    PubMed     Abstract available


  46. OKEMUO AJ, Gallagher D, Dairo YM
    Effects of rebound exercises on balance and mobility of people with neurological disorders: A systematic review.
    PLoS One. 2023;18:e0292312.
    PubMed     Abstract available


  47. GUTOWSKI T, Antkiewicz R, Szlufik S
    Machine learning with optimization to create medicine intake schedules for Parkinson's disease patients.
    PLoS One. 2023;18:e0293123.
    PubMed     Abstract available


  48. PADILHA C, Souza R, Grossl FS, Gauer APM, et al
    Physical exercise and its effects on people with Parkinson's disease: Umbrella review.
    PLoS One. 2023;18:e0293826.
    PubMed     Abstract available


  49. THANPRASERTSUK S, Phowthongkum P, Hopetrungraung T, Poorirerngpoom C, et al
    Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
    PLoS One. 2023;18:e0293516.
    PubMed     Abstract available


  50. LEE SH, Chung KC
    USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
    PLoS One. 2023;18:e0290371.
    PubMed     Abstract available


  51. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
    Pareidolias are a function of visuoperceptual impairment.
    PLoS One. 2023;18:e0293942.
    PubMed     Abstract available


  52. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
    A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    PLoS One. 2023;18:e0294193.
    PubMed     Abstract available


  53. SENA IG, Costa AVD, Santos IKD, Araujo DP, et al
    Feasibility and effect of high-intensity training on the progression of motor symptoms in adult individuals with Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0293357.
    PubMed     Abstract available


  54. MAGANA JC, Deus CM, Baldellou L, Avellanet M, et al
    Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial.
    PLoS One. 2023;18:e0293774.
    PubMed     Abstract available


  55. MORADI VASTEGANI S, Khoshnam SE, Ghafouri S, Bakhtiari N, et al
    Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal alpha-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
    PLoS One. 2023;18:e0294612.
    PubMed     Abstract available


  56. XIN G, Niu J, Tian Q, Fu Y, et al
    Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
    PLoS One. 2023;18:e0294984.
    PubMed     Abstract available


  57. HONG JT, Jung HK, Lee KJ, Gong EJ, et al
    Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
    PLoS One. 2023;18:e0295981.
    PubMed     Abstract available


  58. CHEN L, Xin G, He Y, Tian Q, et al
    Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.
    PLoS One. 2023;18:e0295699.
    PubMed     Abstract available


  59. BORGHESI F, Mancuso V, Bruni F, Cremascoli R, et al
    Mental flexibility assessment: A research protocol for patients with Parkinson's Disease and Anorexia Nervosa.
    PLoS One. 2023;18:e0293921.
    PubMed     Abstract available


  60. MERCER HM, Nair AM, Ridgel A, Piontkivska H, et al
    Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinson's disease.
    PLoS One. 2023;18:e0287078.
    PubMed     Abstract available


  61. HATTORI N, Kabata D, Asada S, Kanda T, et al
    Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.
    PLoS One. 2023;18:e0269969.
    PubMed     Abstract available


    January 2022
  62. HASSIN-BAER S, Cohen OS, Israeli-Korn S, Yahalom G, et al
    Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning.
    PLoS One. 2022;17:e0261947.
    PubMed     Abstract available


  63. PAMPHLETT R, Bishop DP
    Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies.
    PLoS One. 2022;17:e0262464.
    PubMed     Abstract available


  64. HATTORI N, Takeda A, Hanya Y, Kitagawa T, et al
    Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.
    PLoS One. 2022;17:e0262796.
    PubMed     Abstract available


  65. GIGUERE-RANCOURT A, Plourde M, Racine E, Couture M, et al
    Goal management training and psychoeducation / mindfulness for treatment of executive dysfunction in Parkinson's disease: A feasibility pilot trial.
    PLoS One. 2022;17:e0263108.
    PubMed     Abstract available


  66. DIAZ K, Stegemoller EEL
    Electromyographic measures of asymmetric muscle control of swallowing in Parkinson's disease.
    PLoS One. 2022;17:e0262424.
    PubMed     Abstract available


  67. VALKONEN K, Makela JP, Airaksinen K, Nurminen J, et al
    Deep brain stimulation of subthalamic nucleus modulates cortical auditory processing in advanced Parkinson's Disease.
    PLoS One. 2022;17:e0264333.
    PubMed     Abstract available


  68. SHABAN M, Amara AW
    Resting-state electroencephalography based deep-learning for the detection of Parkinson's disease.
    PLoS One. 2022;17:e0263159.
    PubMed     Abstract available


  69. KELEMEN A, Halasz L, Eross L, Rudas G, et al
    Factors affecting postural instability after more than one-year bilateral subthalamic stimulation in Parkinson's disease: A cross-sectional study.
    PLoS One. 2022;17:e0264114.
    PubMed     Abstract available


  70. DISBROW EA, Glassy ND, Dressler EM, Russo K, et al
    Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.
    PLoS One. 2022;17:e0257711.
    PubMed     Abstract available


  71. HSU P, Ready EA, Grahn JA
    The effects of Parkinson's disease, music training, and dance training on beat perception and production abilities.
    PLoS One. 2022;17:e0264587.
    PubMed     Abstract available


  72. GONZALEZ-CASACUBERTA I, Vilas D, Pont-Sunyer C, Tobias E, et al
    Neuronal induction and bioenergetics characterization of human forearm adipose stem cells from Parkinson's disease patients and healthy controls.
    PLoS One. 2022;17:e0265256.
    PubMed     Abstract available


  73. FERRUCCI R, Mameli F, Ruggiero F, Reitano M, et al
    Alternate fluency in Parkinson's disease: A machine learning analysis.
    PLoS One. 2022;17:e0265803.
    PubMed     Abstract available


  74. SCHONENBERG A, Prell T
    Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment.
    PLoS One. 2022;17:e0266140.
    PubMed     Abstract available


  75. LUCIEN F, Benarroch EE, Mullan A, Ali F, et al
    Poly (ADP-Ribose) and alpha-synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity.
    PLoS One. 2022;17:e0264446.
    PubMed     Abstract available


  76. GULKE E, Alsalem M, Kirsten M, Vettorazzi E, et al
    Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson's disease.
    PLoS One. 2022;17:e0265314.
    PubMed     Abstract available


  77. KOH J, Takahashi M, Ohmae Y, Taruya J, et al
    A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson's disease.
    PLoS One. 2022;17:e0266354.
    PubMed     Abstract available


  78. RUONALA V, Pekkonen E, Airaksinen O, Kankaanpaa M, et al
    Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson's disease.
    PLoS One. 2022;17:e0266936.
    PubMed     Abstract available


  79. JOVANOVIC P, Wang Y, Vit JP, Novinbakht E, et al
    Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy.
    PLoS One. 2022;17:e0263074.
    PubMed     Abstract available


  80. VIRBEL-FLEISCHMAN C, Retory Y, Hardy S, Huiban C, et al
    Body-Worn Sensors for Parkinson's disease: A qualitative approach with patients and healthcare professionals.
    PLoS One. 2022;17:e0265438.
    PubMed     Abstract available


  81. BAKKER M, Johnson ME, Corre L, Mill DN, et al
    Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson's disease population: A 3-year, multi-center study.
    PLoS One. 2022;17:e0267969.
    PubMed     Abstract available


  82. MEDINA CA, Vargas E, Munger SJ, Miller JE, et al
    Vocal changes in a zebra finch model of Parkinson's disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway.
    PLoS One. 2022;17:e0265604.
    PubMed     Abstract available


  83. GRAMOTNEV DK, Gramotnev G, Gramotnev A, Summers MJ, et al
    Path analysis of biomarkers for cognitive decline in early Parkinson's disease.
    PLoS One. 2022;17:e0268379.
    PubMed     Abstract available


  84. TROISI LOPEZ E, Minino R, Sorrentino P, Manzo V, et al
    Sensitivity to gait improvement after levodopa intake in Parkinson's disease: A comparison study among synthetic kinematic indices.
    PLoS One. 2022;17:e0268392.
    PubMed     Abstract available


  85. HILL A, Nantel J
    Sensitivity of discrete symmetry metrics: Implications for metric choice.
    PLoS One. 2022;17:e0268581.
    PubMed     Abstract available


  86. SONG J, Lee JH, Choi J, Suh MK, et al
    Detection and differentiation of ataxic and hypokinetic dysarthria in cerebellar ataxia and parkinsonian disorders via wave splitting and integrating neural networks.
    PLoS One. 2022;17:e0268337.
    PubMed     Abstract available


  87. LANDES RD, Glover A, Pillai L, Doerhoff S, et al
    Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype.
    PLoS One. 2022;17:e0269227.
    PubMed     Abstract available


  88. ZINNEN AD, Vichich J, Metzger JM, Gambardella JC, et al
    Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum.
    PLoS One. 2022;17:e0269190.
    PubMed     Abstract available


  89. CHONG-WEN W, Sha-Sha L, Xu E
    Predictors of rapid eye movement sleep behavior disorder in patients with Parkinson's disease based on random forest and decision tree.
    PLoS One. 2022;17:e0269392.
    PubMed     Abstract available


  90. MARKOVIC V, Stankovic I, Radovanovic S, Petrovic I, et al
    Gait alterations in Parkinson's disease at the stage of hemiparkinsonism-A longitudinal study.
    PLoS One. 2022;17:e0269886.
    PubMed     Abstract available


  91. GOLINSKA PB, Bieleninik L, Harciarek M, Bidzan M, et al
    The impact of cognitive impairment of individuals with Parkinson's disease on their caregivers' mental health: A systematic review protocol.
    PLoS One. 2022;17:e0271480.
    PubMed     Abstract available


  92. LI L, Ji B, Zhao T, Cui X, et al
    The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.
    PLoS One. 2022;17:e0269787.
    PubMed     Abstract available


  93. READ J, Frost R, Walters K, Tuijt R, et al
    Transitions and challenges for people with Parkinson's and their family members: A qualitative study.
    PLoS One. 2022;17:e0268588.
    PubMed     Abstract available


  94. SONG MK, Adams L, Lee JH, Kim YS, et al
    NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-alpha-synuclein mouse model of Parkinson's disease.
    PLoS One. 2022;17:e0272085.
    PubMed     Abstract available


  95. HILL MA, Bentley SR, Walker TL, Mellick GD, et al
    Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?
    PLoS One. 2022;17:e0271499.
    PubMed     Abstract available


  96. HEARN R, Selfe J, Cordero MI, Dobbin N, et al
    The effects of active rehabilitation on symptoms associated with tau pathology: An umbrella review. Implications for chronic traumatic encephalopathy symptom management.
    PLoS One. 2022;17:e0271213.
    PubMed     Abstract available


  97. SONG S, Luo Z, Li C, Huang X, et al
    Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis.
    PLoS One. 2022;17:e0272315.
    PubMed     Abstract available


  98. CHEN HC, Wang CY, Chen HH, Liou HH, et al
    Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.
    PLoS One. 2022;17:e0269006.
    PubMed     Abstract available


  99. SHAH R, Read J, Davies N, Nimmons D, et al
    People with Parkinson's perspectives and experiences of self-management: Qualitative findings from a UK study.
    PLoS One. 2022;17:e0273428.
    PubMed     Abstract available


  100. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0272559.
    PubMed     Abstract available


  101. SNODERLY-FOSTER LJ, Olivas WM
    Regulation of Parkinson's disease-associated genes by Pumilio proteins and microRNAs in SH-SY5Y neuronal cells.
    PLoS One. 2022;17:e0275235.
    PubMed     Abstract available


  102. DAS J, Morris R, Barry G, Vitorio R, et al
    Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial.
    PLoS One. 2022;17:e0275738.
    PubMed     Abstract available


  103. BARCENAS R, Fuentes-Garcia R, Naranjo L
    Mixed kernel SVR addressing Parkinson's progression from voice features.
    PLoS One. 2022;17:e0275721.
    PubMed     Abstract available


  104. RAZALI K, Mohd Nasir MH, Othman N, Doolaanea AA, et al
    Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study.
    PLoS One. 2022;17:e0274844.
    PubMed     Abstract available


  105. TORRADO JC, Husebo BS, Allore HG, Erdal A, et al
    Digital phenotyping by wearable-driven artificial intelligence in older adults and people with Parkinson's disease: Protocol of the mixed method, cyclic ActiveAgeing study.
    PLoS One. 2022;17:e0275747.
    PubMed     Abstract available


  106. DE GOES MCR, Sarmento A, Lima I, Lyra M, et al
    After-effects of thixotropic conditionings on operational chest wall and compartmental volumes of patients with Parkinson's disease.
    PLoS One. 2022;17:e0275584.
    PubMed     Abstract available


  107. MIKOLAIZAK AS, Rochester L, Maetzler W, Sharrack B, et al
    Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement-the Mobilise-D study protocol.
    PLoS One. 2022;17:e0269615.
    PubMed     Abstract available


  108. BAKER S, Tekriwal A, Felsen G, Christensen E, et al
    Automatic extraction of upper-limb kinematic activity using deep learning-based markerless tracking during deep brain stimulation implantation for Parkinson's disease: A proof of concept study.
    PLoS One. 2022;17:e0275490.
    PubMed     Abstract available


  109. WAIRAGKAR M, Villeneuve E, King R, Janko B, et al
    A novel approach for modelling and classifying sit-to-stand kinematics using inertial sensors.
    PLoS One. 2022;17:e0264126.
    PubMed     Abstract available


  110. LAMA J, Salabasidou E, Volkmann J, Kuzkina A, et al
    Proinflammatory profile in the skin of Parkinson's disease patients with and without pain.
    PLoS One. 2022;17:e0276564.
    PubMed     Abstract available


  111. LOWIT A, Thies T, Steffen J, Scheele F, et al
    Task-based profiles of language impairment and their relationship to cognitive dysfunction in Parkinson's disease.
    PLoS One. 2022;17:e0276218.
    PubMed     Abstract available


  112. OWEN CL, Gaulton C, Roberts HC, Dennison L, et al
    Perceptions of people with Parkinson's and their caregivers of falling and falls-related healthcare services- a qualitative study.
    PLoS One. 2022;17:e0276588.
    PubMed     Abstract available


  113. KOMAGAMINE T, Suzuki K, Kokubun N, Komagamine J, et al
    Sleep-related hallucinations in patients with Parkinson's disease.
    PLoS One. 2022;17:e0276736.
    PubMed     Abstract available



  114. Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0277781.
    PubMed     Abstract available


  115. BEK J, Leventhal D, Groves M, Growcott C, et al
    Moving online: Experiences and potential benefits of digital dance for older adults and people with Parkinson's disease.
    PLoS One. 2022;17:e0277645.
    PubMed     Abstract available


  116. VITORIO R, Morris R, Das J, Walker R, et al
    Brain activity response to cues during gait in Parkinson's disease: A study protocol.
    PLoS One. 2022;17:e0275894.
    PubMed     Abstract available


  117. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
    Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0278279.
    PubMed     Abstract available


  118. JOLA C, Sundstrom M, McLeod J
    Benefits of dance for Parkinson's: The music, the moves, and the company.
    PLoS One. 2022;17:e0265921.
    PubMed     Abstract available


  119. DIERIKS BV, Highet B, Alik A, Bellande T, et al
    Human pericytes degrade diverse alpha-synuclein aggregates.
    PLoS One. 2022;17:e0277658.
    PubMed     Abstract available


  120. RAJA WK, Neves E, Burke C, Jiang X, et al
    Patient-derived three-dimensional cortical neurospheres to model Parkinson's disease.
    PLoS One. 2022;17:e0277532.
    PubMed     Abstract available


  121. HATORI Y, Kanda Y, Nonaka S, Nakanishi H, et al
    ATP13A2 modifies mitochondrial localization of overexpressed TOM20 to autolysosomal pathway.
    PLoS One. 2022;17:e0276823.
    PubMed     Abstract available


  122. NADEEM H, Zhou B, Goldman D, Romley J, et al
    Association between use of ss2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis.
    PLoS One. 2022;17:e0276368.
    PubMed     Abstract available


  123. SHINOHARA M, Yokoi K, Hirayama K, Kanno S, et al
    Mirror writing and cortical hypometabolism in Parkinson's disease.
    PLoS One. 2022;17:e0279007.
    PubMed     Abstract available


  124. OIZUMI H, Sugimura Y, Totsune T, Kawasaki I, et al
    Plasma sphingolipid abnormalities in neurodegenerative diseases.
    PLoS One. 2022;17:e0279315.
    PubMed     Abstract available


  125. OGAWA T, Kajiyama Y, Ishido H, Chiba S, et al
    Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study.
    PLoS One. 2022;17:e0279747.
    PubMed     Abstract available


    January 2021
  126. BOUSSAC M, Arbus C, Dupouy J, Harroch E, et al
    Personality dimensions of patients can change during the course of parkinson's disease.
    PLoS One. 2021;16:e0245142.
    PubMed     Abstract available


  127. KAMIENIARZ A, Michalska J, Marszalek W, Stania M, et al
    Detection of postural control in early Parkinson's disease: Clinical testing vs. modulation of center of pressure.
    PLoS One. 2021;16:e0245353.
    PubMed     Abstract available


  128. KITANI-MORII F, Kasai T, Horiguchi G, Teramukai S, et al
    Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan.
    PLoS One. 2021;16:e0245864.
    PubMed     Abstract available


  129. SHALASH AS, Hamid E, Elrassas H, Bahbah EI, et al
    Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease.
    PLoS One. 2021;16:e0245918.
    PubMed     Abstract available


  130. FORNS J, Layton JB, Bartsch J, Turner ME, et al
    Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    PLoS One. 2021;16:e0246121.
    PubMed     Abstract available


  131. PARK KH, Sun S, Lim YH, Park HR, et al
    Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease.
    PLoS One. 2021;16:e0244133.
    PubMed     Abstract available


  132. MAHMOUDZADEH M, Wallois F, Tir M, Krystkowiak P, et al
    Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy.
    PLoS One. 2021;16:e0245188.
    PubMed     Abstract available


  133. LIN I, Edison B, Mantri S, Albert S, et al
    Triggers and alleviating factors for fatigue in Parkinson's disease.
    PLoS One. 2021;16:e0245285.
    PubMed     Abstract available


  134. SICA M, Tedesco S, Crowe C, Kenny L, et al
    Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review.
    PLoS One. 2021;16:e0246528.
    PubMed     Abstract available


  135. OVEISGHARAN S, Yu L, Bennett DA, Buchman AS, et al
    Incident mobility disability, parkinsonism, and mortality in community-dwelling older adults.
    PLoS One. 2021;16:e0246206.
    PubMed     Abstract available


  136. NAGANO T, Kakuma T, Umezu Y, Yanagawa T, et al
    Nutritional status and activities of daily living in patients with Parkinson's disease.
    PLoS One. 2021;16:e0246329.
    PubMed     Abstract available


  137. BURIL J, Burilova P, Pokorna A, Kovacova I, et al
    Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study.
    PLoS One. 2021;16:e0246342.
    PubMed     Abstract available



  138. Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
    PLoS One. 2021;16:e0247151.
    PubMed    


  139. LEE JW, Song YS, Kim H, Ku BD, et al
    Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data.
    PLoS One. 2021;16:e0246881.
    PubMed     Abstract available


  140. IIJIMA M, Okuma Y, Suzuki K, Yoshii F, et al
    Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
    PLoS One. 2021;16:e0247443.
    PubMed     Abstract available


  141. VARRECCHIA T, Castiglia SF, Ranavolo A, Conte C, et al
    An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters.
    PLoS One. 2021;16:e0244396.
    PubMed     Abstract available


  142. AGURTO C, Heisig S, Abrami A, Ho BK, et al
    Parkinson's disease medication state and severity assessment based on coordination during walking.
    PLoS One. 2021;16:e0244842.
    PubMed     Abstract available


  143. BARGIOTAS I, Kalogeratos A, Limnios M, Vidal PP, et al
    Revealing posturographic profile of patients with Parkinsonian syndromes through a novel hypothesis testing framework based on machine learning.
    PLoS One. 2021;16:e0246790.
    PubMed     Abstract available


  144. DZIECIOL K, Iordanishvili E, Abbas Z, Nahimi A, et al
    A robust method for the detection of small changes in relaxation parameters and free water content in the vicinity of the substantia nigra in Parkinson's disease patients.
    PLoS One. 2021;16:e0247552.
    PubMed     Abstract available


  145. JEONG S, Cho H, Kim YJ, Ma HI, et al
    Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
    PLoS One. 2021;16:e0247354.
    PubMed     Abstract available


  146. PHAM U, Skogseid IM, Pripp AH, Boen E, et al
    Impulsivity in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation-An exploratory study.
    PLoS One. 2021;16:e0248568.
    PubMed     Abstract available


  147. MANTRI S, Klawson E, Albert S, Rapoport R, et al
    The experience of care partners of patients with Parkinson's disease psychosis.
    PLoS One. 2021;16:e0248968.
    PubMed     Abstract available


  148. SEBATE B, Cuttler K, Cloete R, Britz M, et al
    Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
    PLoS One. 2021;16:e0249324.
    PubMed     Abstract available


  149. LOVEGROVE CJ, Bannigan K
    What is the lived experience of anxiety for people with Parkinson's? A phenomenological study.
    PLoS One. 2021;16:e0249390.
    PubMed     Abstract available


  150. SIRAGY T, Hill A, Nantel J
    Recovery of dynamic stability during slips unaffected by arm swing in people with Parkinson's Disease.
    PLoS One. 2021;16:e0249303.
    PubMed     Abstract available



  151. Correction: A genetic analysis of a Spanish population with early onset Parkinson's disease.
    PLoS One. 2021;16:e0249805.
    PubMed     Abstract available


  152. JENSEN BR, Malling ASB, Schmidt SI, Meyer M, et al
    Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease.
    PLoS One. 2021;16:e0248800.
    PubMed     Abstract available


  153. SORBERA C, Brigandi A, Cimino V, Bonanno L, et al
    The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
    PLoS One. 2021;16:e0251313.
    PubMed     Abstract available


  154. KROTINGER A, Loui P
    Rhythm and groove as cognitive mechanisms of dance intervention in Parkinson's disease.
    PLoS One. 2021;16:e0249933.
    PubMed     Abstract available


  155. LOLEKHA P, Sriphanom T, Vilaichone RK
    Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
    PLoS One. 2021;16:e0251042.
    PubMed     Abstract available


  156. FREIDLE M, Johansson H, Lebedev AV, Ekman U, et al
    Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson s disease: A feasibility study.
    PLoS One. 2021;16:e0251849.
    PubMed     Abstract available


  157. SHRESTHA S, Parks CG, Richards-Barber M, Chen H, et al
    Parkinson's disease case ascertainment in a large prospective cohort.
    PLoS One. 2021;16:e0251852.
    PubMed     Abstract available


  158. MCKAY JL, Lang KC, Bong SM, Hackney ME, et al
    Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
    PLoS One. 2021;16:e0252119.
    PubMed     Abstract available


  159. RODRIGUEZ-SABATE C, Rodriguez M, Morales I
    Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.
    PLoS One. 2021;16:e0252565.
    PubMed     Abstract available


  160. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2021;16:e0252988.
    PubMed     Abstract available


  161. SHENG MZ, Fang TC, Chen YH, Chang MH, et al
    Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
    PLoS One. 2021;16:e0252451.
    PubMed     Abstract available


  162. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available


  163. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available


  164. PEARCE P, Bulluss K, Xu SS, Kim B, et al
    How accurately are subthalamic nucleus electrodes implanted relative to the ideal stimulation location for Parkinson's disease?
    PLoS One. 2021;16:e0254504.
    PubMed     Abstract available


  165. KOYANAGI Y, Fukushi I, Nakamura M, Suzuki K, et al
    The effect of body weight-supported overground gait training for patients with Parkinson's disease: A retrospective case-control observational study.
    PLoS One. 2021;16:e0254415.
    PubMed     Abstract available


  166. TAGUCHI S, Koide H, Oiwa H, Hayashi M, et al
    Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
    PLoS One. 2021;16:e0255274.
    PubMed     Abstract available


  167. VACCARI C, Grotto D, Pereira TDV, de Camargo JLV, et al
    GLP-1 and GIP receptor agonists in the treatment of Parkinson's disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies.
    PLoS One. 2021;16:e0255726.
    PubMed     Abstract available


  168. WARDEN MN, Searles Nielsen S, Camacho-Soto A, Garnett R, et al
    A comparison of prediction approaches for identifying prodromal Parkinson disease.
    PLoS One. 2021;16:e0256592.
    PubMed     Abstract available


  169. ARISTOTELIDOU V, Tsatali M, Overton PG, Vivas AB, et al
    Autonomic factors do not underlie the elevated self-disgust levels in Parkinson's disease.
    PLoS One. 2021;16:e0256144.
    PubMed     Abstract available


  170. BRAKEDAL B, Tzoulis C, Tysnes OB, Haugarvoll K, et al
    NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
    PLoS One. 2021;16:e0256602.
    PubMed     Abstract available


  171. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    PubMed     Abstract available


  172. PARDOEL S, Shalin G, Lemaire ED, Kofman J, et al
    Grouping successive freezing of gait episodes has neutral to detrimental effect on freeze detection and prediction in Parkinson's disease.
    PLoS One. 2021;16:e0258544.
    PubMed     Abstract available


  173. AOUN K, Double KL, Pearson-Dennett V, Yilmaz R, et al
    Measurement of the adult human midbrain with transcranial ultrasound.
    PLoS One. 2021;16:e0247920.
    PubMed     Abstract available


  174. MA A, Lau KK, Thyagarajan D
    Radiological correlates of vocal fold bowing as markers of Parkinson's disease progression: A cross-sectional study utilizing dynamic laryngeal CT.
    PLoS One. 2021;16:e0258786.
    PubMed     Abstract available


  175. AHN JH, Seok JM, Park J, Jeong H, et al
    Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.
    PLoS One. 2021;16:e0258897.
    PubMed     Abstract available


  176. PRELL T, Liebermann JD, Mendorf S, Lehmann T, et al
    Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study.
    PLoS One. 2021;16:e0257966.
    PubMed     Abstract available


  177. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    PubMed     Abstract available


  178. NEJTEK VA, James RN, Salvatore MF, Alphonso HM, et al
    Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.
    PLoS One. 2021;16:e0258851.
    PubMed     Abstract available


  179. SHAMADYKOVA DV, Panteleev DY, Kust NN, Savchenko EA, et al
    Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells.
    PLoS One. 2021;16:e0258289.
    PubMed     Abstract available


  180. ELFARRASH S, Jensen NM, Ferreira N, Schmidt SI, et al
    Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
    PLoS One. 2021;16:e0252635.
    PubMed     Abstract available


  181. WITT VD, Baur G, Ecke J, Kirchner A, et al
    Parkinson's patients situation during the SARS CoV-2 pandemic and their interest in telemedicine A cross-sectional study.
    PLoS One. 2021;16:e0260317.
    PubMed     Abstract available


  182. DEL PINO R, Murueta-Goyena A, Ayala U, Acera M, et al
    Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease.
    PLoS One. 2021;16:e0259935.
    PubMed     Abstract available


  183. RICHARD P, Kozlowski L, Guillorit H, Garnier P, et al
    Queuine, a bacterial-derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration.
    PLoS One. 2021;16:e0253216.
    PubMed     Abstract available


  184. HAYNES JM, Sibuea SM, Aguiar AA, Li F, et al
    Inhibition of beta-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson's disease.
    PLoS One. 2021;16:e0261730.
    PubMed     Abstract available


  185. VIRAMETEEKUL S, Phokaewvarangkul O, Bhidayasiri R
    Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?
    PLoS One. 2021;16:e0261302.
    PubMed     Abstract available


  186. CUBO E, Garcia-Bustillo A, Arnaiz-Gonzalez A, Ramirez-Sanz JM, et al
    Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial.
    PLoS One. 2021;16:e0260889.
    PubMed     Abstract available


  187. FRANSSON PA, Nilsson MH, Rehncrona S, Tjernstrom F, et al
    Deep brain stimulation in the subthalamic nuclei alters postural alignment and adaptation in Parkinson's disease.
    PLoS One. 2021;16:e0259862.
    PubMed     Abstract available


  188. MAKAI-BOLONI S, Thijssen E, van Brummelen EMJ, Groeneveld GJ, et al
    Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance.
    PLoS One. 2021;16:e0260783.
    PubMed     Abstract available


  189. FRANKEMOLLE-GILBERT AM, Howell B, Bower KL, Veltink PH, et al
    Comparison of methodologies for modeling directional deep brain stimulation electrodes.
    PLoS One. 2021;16:e0260162.
    PubMed     Abstract available


    January 2020
  190. GAARE JJ, Nido G, Dolle C, Sztromwasser P, et al
    Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
    PLoS One. 2020;15:e0239824.
    PubMed     Abstract available


  191. SATO K, Mano T, Iwata A, Toda T, et al
    Autocorrelation-based method to identify disordered rhythm in Parkinson's disease tasks: A novel approach applicable to multimodal devices.
    PLoS One. 2020;15:e0238486.
    PubMed     Abstract available


  192. MONSELLIER E, Bendifallah M, Redeker V, Melki R, et al
    Polypeptides derived from alpha-Synuclein binding partners to prevent alpha-Synuclein fibrils interaction with and take-up by cells.
    PLoS One. 2020;15:e0237328.
    PubMed     Abstract available


  193. GLASS TJ, Kelm-Nelson CA, Szot JC, Lake JM, et al
    Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2020;15:e0240366.
    PubMed     Abstract available


  194. TANAKA R, Yamashiro K, Ogawa T, Oyama G, et al
    The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.
    PLoS One. 2020;15:e0240491.
    PubMed     Abstract available


  195. KUBOTA M, Kobayashi N, Sugizaki T, Shimoda M, et al
    Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
    PLoS One. 2020;15:e0240448.
    PubMed     Abstract available


  196. MORI Y, Yoshikawa E, Futatsubashi M, Ouchi Y, et al
    Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction.
    PLoS One. 2020;15:e0240998.
    PubMed     Abstract available



  197. Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson's disease in a rhesus monkey model.
    PLoS One. 2020;15:e0242032.
    PubMed    


  198. JENG B, Cederberg KLJ, Lai B, Sasaki JE, et al
    Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease.
    PLoS One. 2020;15:e0242136.
    PubMed     Abstract available


  199. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0240855.
    PubMed     Abstract available


  200. MALINOVA V, Pinter A, Dragaescu C, Rohde V, et al
    The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease.
    PLoS One. 2020;15:e0241752.
    PubMed     Abstract available


  201. MURUGAPPAN M, Alshuaib W, Bourisly AK, Khare SK, et al
    Tunable Q wavelet transform based emotion classification in Parkinson's disease using Electroencephalography.
    PLoS One. 2020;15:e0242014.
    PubMed     Abstract available


  202. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2020;15:e0243051.
    PubMed     Abstract available


  203. PINTO C, Salazar AP, Hennig EM, Kerr G, et al
    Dual-task walking reduces lower limb range of motion in individuals with Parkinson's disease and freezing of gait: But does it happen during what events through the gait cycle?
    PLoS One. 2020;15:e0243133.
    PubMed     Abstract available


  204. BAUMANN-VOGEL H, Hor H, Poryazova R, Valko P, et al
    REM sleep behavior in Parkinson disease: Frequent, particularly with higher age.
    PLoS One. 2020;15:e0243454.
    PubMed     Abstract available


  205. ANDERSSON N, Nilsson MH, Slaug B, Oswald F, et al
    The meaning of home questionnaire revisited: Psychometric analyses among people with Parkinson's disease reveals new dimensions.
    PLoS One. 2020;15:e0242792.
    PubMed     Abstract available


  206. TORTI M, Fossati C, Casali M, De Pandis MF, et al
    Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study.
    PLoS One. 2020;15:e0243612.
    PubMed     Abstract available


  207. PETROZZIELLO T, Dios AM, Mueller KA, Vaine CA, et al
    SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    PLoS One. 2020;15:e0243655.
    PubMed     Abstract available


  208. POLAKOVA K, Ruzicka E, Jech R, Kemlink D, et al
    3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN.
    PLoS One. 2020;15:e0244676.
    PubMed     Abstract available


  209. IBRAHIM A, Ali RAR, Manaf MRA, Ahmad N, et al
    Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.
    PLoS One. 2020;15:e0244680.
    PubMed     Abstract available


  210. SHIM M, Bang WJ, Oh CY, Lee YS, et al
    Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0244660.
    PubMed     Abstract available


  211. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0244776.
    PubMed     Abstract available


  212. EHLEN F, Al-Fatly B, Kuhn AA, Klostermann F, et al
    Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease.
    PLoS One. 2020;15:e0244148.
    PubMed     Abstract available


  213. PRAVEEN RAJNEESH C, Liou JC, Hsieh TH, Lin JH, et al
    The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.
    PLoS One. 2020;15:e0243452.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.